Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early rhBNP on Myocardial Work in Anterior STEMI After PCI
NCT04157868Phase 4Unknown
- Sponsor
- Renji Hospital
- Start
- Nov 2019
- Primary completion
- Sep 2022
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised trial of nesiritide in ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Renji Hospital. Primary endpoint: Global myocardial work efficiency by echocardiography at 30 days. Status: unknown.
02
Drugs
nesiritide
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT04157868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04157868.